Evome Medical Technologies Inc.
EVMT.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.51% | 47.50% | 72.65% | -621.67% | 368.24% |
| Total Depreciation and Amortization | -0.77% | -20.72% | 232.65% | -132.53% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.74% | 561.19% | -95.41% | 421.83% | -554.56% |
| Change in Net Operating Assets | 555.10% | -123.51% | 65.71% | 178.02% | -- |
| Cash from Operations | -42.62% | 602.67% | -155.76% | 190.80% | -- |
| Capital Expenditure | -- | 100.00% | -261.93% | 117.62% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -261.93% | 101.63% | -- |
| Total Debt Issued | 775.74% | -- | -- | -135.31% | -- |
| Total Debt Repaid | -0.03% | -971.14% | -60.88% | -141.92% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.90% | -908.03% | 83.32% | -623.68% | -- |
| Foreign Exchange rate Adjustments | -25.98% | 47.82% | -20.23% | 25.05% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.55% | 220.80% | -416.95% | 95.00% | -- |